Partners in Health and Research Development, Thika, Kenya.
Faculty of Health Sciences, Wits Reproductive Health & HIV Institute (Wits RHI), University of the Witwatersrand, Johannesburg, South Africa.
Curr HIV/AIDS Rep. 2021 Dec;18(6):490-499. doi: 10.1007/s11904-021-00576-9. Epub 2021 Oct 31.
PURPOSE OF REVIEW: This review summarizes interventions to promote HIV pre-exposure prophylaxis (PrEP) use among adolescent girls and young women (AGYW) in HIV endemic settings, while also highlighting gaps in our current measures of PrEP intervention success. RECENT FINDINGS: AGYW report challenges with PrEP use, although the field is currently grappling with defining metrics of optimal PrEP use applicable for AGYW with dynamic HIV prevention needs. Ongoing studies are exploring multilevel interventions to address barriers to PrEP use for AGYW. At the individual and interpersonal levels, mHealth, drug-level feedback, adherence counseling, peer groups, and PrEP decision-support interventions are acceptable and feasible for AGYW although limited effectiveness data are available. At the health facility and community levels, PrEP demand creation, modified PrEP refill schedules, and integrated PrEP and reproductive health services are also promising options to support PrEP use for AGYW. As PrEP delivery continues to expand, improved metrics of success and evidence on the effectiveness of multi-level adherence support interventions are needed to maximize the impact of PrEP for AGYW in HIV endemic settings. We present case studies of these intervention approaches but limited data are currently available on the effectiveness of these approaches. We will look toward forthcoming study results on the impact of PrEP interventions, including mHealth, drug-level feedback and other enhanced counseling, peer support, decision-support tools, PrEP demand creation, modified refills, and integrated service delivery, to determine the ideal package of PrEP support approaches for AGYW.
目的综述:本综述总结了在艾滋病毒流行地区促进青少年女孩和年轻妇女(AGYW)使用艾滋病毒暴露前预防(PrEP)的干预措施,同时强调了我们目前衡量 PrEP 干预成功的措施存在差距。
最近的发现:AGYW 报告了 PrEP 使用方面的挑战,尽管该领域目前正在努力定义适用于具有动态艾滋病毒预防需求的 AGYW 的最佳 PrEP 使用指标。正在进行的研究正在探索多层次的干预措施,以解决 AGYW 使用 PrEP 的障碍。在个人和人际层面上,移动医疗、药物水平反馈、依从性咨询、同伴小组和 PrEP 决策支持干预措施对于 AGYW 来说是可以接受和可行的,尽管可用的数据有限。在卫生机构和社区层面上,PrEP 需求创造、修改 PrEP 续药时间表以及整合 PrEP 和生殖健康服务也是支持 AGYW 使用 PrEP 的有希望的选择。随着 PrEP 服务的不断扩展,需要改进成功的衡量标准和多层面依从性支持干预措施的有效性证据,以最大限度地提高 PrEP 在艾滋病毒流行地区对 AGYW 的影响。我们提出了这些干预方法的案例研究,但目前关于这些方法有效性的数据有限。我们将关注即将公布的关于 PrEP 干预措施(包括移动医疗、药物水平反馈和其他增强型咨询、同伴支持、决策支持工具、PrEP 需求创造、修改续药以及整合服务提供)对 PrEP 影响的研究结果,以确定最适合 AGYW 的 PrEP 支持方法的理想方案。
PLOS Glob Public Health. 2025-5-27
J Acquir Immune Defic Syndr. 2021-5-1
BMC Health Serv Res. 2020-11-12